Myelofibrosis

Overview

Myelofibrosis is a type of chronic leukemia — a blood cancer that affects your bone marrow, disrupting normal production of blood cells. Myelofibrosis can occur on its own or it can occur as a result of another bone marrow disorder. The severity of myelofibrosis and the outlook for people with this disease are quite variable. In some people, the disease remains stable for years without treatment. Others will be very sick at the time of diagnosis, and treatment can be complicated.

Why choose Mayo Clinic for myelofibrosis

• Expertise and experience. Specialists evaluate and treat hundreds of people with myelofibrosis each year at Mayo Clinic in Arizona, Minnesota and Florida. A designated group of specialists, the Myeloproliferative Subgroup, specifically focuses on treating myelofibrosis and similar diseases. Mayo Clinic doctors have significant expertise in using the newest medications and therapies to treat myelofibrosis.
• Latest research and treatments. For many years, Mayo Clinic has continuously tested new medications and therapies to determine which ones might effectively manage myelofibrosis and provide new treatment options. Mayo Clinic offers clinical trials based on the latest treatment advances. Mayo Clinic's experienced doctors and surgeons work together as a team to create a customized myelofibrosis treatment plan for you, giving you access to the latest treatment options.
• Comprehensive cancer center. Designated as a comprehensive cancer center by the National Cancer Institute, the Mayo Clinic Cancer Center provides state-of-the-art care and treatment services, and is a leader in translating knowledge gained from cancer research into effective improvements in patient care.

Why Choose Mayo Clinic
What Sets Mayo Clinic Apart

Read more about myelofibrosis.